Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy

被引：1

作者：

Tinelli, Michela M. ^{[1
]}

Roddy, Aine ^{[1
,7
]}

Knapp, Martin ^{[1
]}

Arango, Celso ^{[2
]}

Mendez, Maria Andreina ^{[2
]}

Cusack, James ^{[3
]}

Murphy, Declan ^{[4
]}

Canitano, Roberto ^{[5
]}

Oakley, Bethany ^{[4
]}

Quoidbach, Vinciane ^{[6
]}

机构：

[1] London Sch Econ & Polit Sci, Care Policy & Evaluat Ctr, London, England

[2] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Psychiat & Mental Hlth, Sch Med,Dept Child & Adolescent Psychiat,CIBERSAM,, Madrid, Spain

[3] Autistica, London, England

[4] Kings Coll London, London, England

[5] Azienda Osped Univ Senese, Azienda, Siena, Italy

[6] European Brain Council, Brussels, Belgium

[7] Atlantic Technol Univ, Sligo, Ireland

来源：

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS | 2024年 / 54卷 / 07期

基金：

欧盟地平线“2020”;

关键词：

Autism; Epilepsy; Children; Cost-effectiveness; Healthcare expenditure; Family impacts; COST-EFFECTIVENESS; ACTIVE EPILEPSY; YOUNG-ADULTS; CARE COSTS; CHILDHOOD; HEALTH; CONSEQUENCES; EDUCATION; DISORDER; IMPACT;

D O I：

10.1007/s10803-023-05941-8

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure.

引用

页码：2733 / 2741

页数：9

共 50 条

[11] Epilepsy syndrome-specific anti-epileptic drug therapy for children
Trevathan, E
LANCET, 2000, 356 (9242): : 1623 - 1624
[12] Incidence of Epilepsy and Anti-Epileptic Drug (AED) Prescribing in Children in the UK
Meeraus, W. H.
Gilbert, R.
Chin, R. F.
Petersen, I.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S226 - S226
[13] Requirements for generic anti-epileptic medicines: a regulatory perspective
Maliepaard, Marc
Hekster, Yechiel A.
Kappelle, Arnoud
van Puijenbroek, Eugene P.
Elferink, Andre J.
Welink, Jan
Gispen-de Wied, Christine C.
Lekkerkerker, Frits J. F.
JOURNAL OF NEUROLOGY, 2009, 256 (12) : 1966 - 1971
[14] Requirements for generic anti-epileptic medicines: a regulatory perspective
Marc Maliepaard
Yechiel A. Hekster
Arnoud Kappelle
Eugène P. van Puijenbroek
André J. Elferink
Jan Welink
Christine C. Gispen-de Wied
Frits J. F. Lekkerkerker
Journal of Neurology, 2009, 256 : 1966 - 1971
[15] 2 ANTI-EPILEPTIC DRUGS FOR INTRACTABLE EPILEPSY
SCHMIDT, D
EPILEPSIA, 1983, 24 (02) : 254 - 254
[16] Teratogenic effects of epilepsy and anti-epileptic drugs
Campistol, J
REVISTA DE NEUROLOGIA, 2002, 35 : S135 - S143
[17] ADHERENCE TO ANTI-EPILEPTIC MEDICATION IN CHILDREN WITH EPILEPSY FROM A SCOTTISH POPULATION COHORT
Shetty, Jay
Greene, S.
Kirkpatrick, M.
EPILEPSIA, 2008, 49 : 94 - 95
[18] Influence of anti-epileptic treatment on academic performance of children with partial onset epilepsy
Pestana, EM
Sardinas, NL
Trujillo, C
de Armas, AI
Zarrabeitia, L
EPILEPSIA, 1999, 40 : 114 - 114
[19] MULTIPLE ANTI-EPILEPTIC DRUG USE IN CHILDREN WITH EPILEPSY; THE PREVALENCE AND ASSOCIATED FACTORS
Atugonza, R.
Idro, R.
Kakooza-Mwesige, A.
EPILEPSIA, 2014, 55 : 112 - 112
[20] Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy
Chen, B.
Detyniecki, K.
Choi, H.
Hirsch, L.
Katz, A.
Legge, A.
Wong, R.
Jiang, A.
Buchsbaum, R.
Farooque, P.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2017, 21 (03) : 441 - 449

← 1 2 3 4 5 →